Citius Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cranford, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Citius Pharmaceuticals, Inc. has filed 629 SEC EDGAR filings since 23 Nov 2010

SEC filing history

Showing 176-200 of 629 matching filings.

Per page
25
Current page
8
8-K File 001-38174

CURRENT REPORT

Filing date
22 Sep 2022
Reporting date
22 Sep 2022
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
11 Aug 2022
Reporting date
11 Aug 2022
Next action
Verify source filing
10-Q File 001-38174

QUARTERLY REPORT

Filing date
11 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
25-NSE File 001-38174

25-NSE filing

Filing date
08 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
12 Jul 2022
Reporting date
12 Jul 2022
Next action
Verify source filing
SC 13G File 005-90253

SC 13G filing

Filing date
08 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
25 May 2022
Reporting date
25 May 2022
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
12 May 2022
Reporting date
12 May 2022
Next action
Verify source filing
10-Q File 001-38174

QUARTERLY REPORT

Filing date
12 May 2022
Reporting date
31 Mar 2022
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT FILING

Filing date
06 May 2022
Reporting date
06 May 2022
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT FILING

Filing date
26 Apr 2022
Reporting date
26 Apr 2022
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT FILING

Filing date
13 Apr 2022
Reporting date
12 Apr 2022
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
06 Apr 2022
Reporting date
06 Apr 2022
Next action
Verify source filing
SC 13D/A File 005-90253

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
18 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90253

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
18 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
15 Feb 2022
Reporting date
15 Feb 2022
Next action
Verify source filing
SC 13G/A File 005-90253

SC 13G/A

Filing date
15 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
10 Feb 2022
Reporting date
10 Feb 2022
Next action
Verify source filing
10-Q File 001-38174

QUARTERLY REPORT

Filing date
10 Feb 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
08 Feb 2022
Reporting date
08 Feb 2022
Next action
Verify source filing
SC 13G File 005-90253

SC 13G filing

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38174

DEFINITIVE ADDITIONAL MATERIALS

Filing date
20 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38174

DEFINITIVE PROXY STATEMENT

Filing date
20 Dec 2021
Reporting date
08 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-38174

ANNUAL REPORT

Filing date
15 Dec 2021
Reporting date
30 Sep 2021
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
15 Dec 2021
Reporting date
15 Dec 2021
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .